Walleye Trading LLC Sanofi Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

30 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $1.68 Million - $2.03 Million	34,600 Added 9.41%	402,200 $23.2 Million
Q2 2024 Aug 14, 2024	SELL	$45.39 - $50.36 $1.16 Million - $1.28 Million	-25,500 Reduced 6.49%	367,600 $17.8 Million
Q1 2024 May 15, 2024	SELL	$45.75 - $52.48 $7.25 Million - $8.32 Million	-158,500 Reduced 28.73%	393,100 $19.1 Million
Q4 2023 Feb 14, 2024	BUY	$43.13 - $54.79 $254,467 - $323,261	5,900 Added 1.08%	551,600 $27.4 Million
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $2.44 Million - $2.64 Million	47,900 Added 9.62%	545,700 $29.3 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $6.71 Million - $7.6 Million	-133,000 Reduced 21.08%	497,800 $26.8 Million
Q1 2023 May 15, 2023	BUY	$45.86 - $54.45 $24.4 Million - $29 Million	532,400 Added 541.06%	630,800 $34.3 Million
Q4 2022 Feb 14, 2023	BUY	$38.86 - $48.55 $1.58 Million - $1.97 Million	40,600 Added 70.24%	98,400 $4.77 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $1.84 Million - $4.97 Million	49,500 Added 596.39%	57,800 $2.2 Million
Q2 2022 Aug 08, 2022	SELL	$48.99 - $57.46 $793,638 - $930,852	-16,200 Reduced 66.12%	8,300 $415,000
Q1 2022 May 16, 2022	SELL	$48.48 - $53.65 $1.8 Million - $2 Million	-37,200 Reduced 60.29%	24,500 $1.26 Million
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $941,400 - $1.05 Million	20,000 Added 47.96%	61,700 $3.09 Million
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $1.67 Million - $1.85 Million	34,900 Added 513.24%	41,700 $2.01 Million
Q2 2021 Aug 16, 2021	SELL	$49.36 - $54.25 $878,608 - $965,650	-17,800 Reduced 72.36%	6,800 $358,000
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $554,612 - $616,222	12,200 Added 98.39%	24,600 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $51.62 $22,650 - $25,810	-500 Reduced 3.88%	12,400 $603,000
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $301,767 - $327,997	-6,100 Reduced 32.11%	12,900 $647,000
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $244,586 - $299,250	5,700 Added 42.86%	19,000 $970,000
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $376,398 - $511,433	9,900 Added 291.18%	13,300 $581,000
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $115,050 - $132,236	2,600 Added 325.0%	3,400 $171,000
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $1.5 Million - $1.73 Million	-37,100 Reduced 97.89%	800 $37,000
Q2 2019 Aug 14, 2019	BUY	$40.43 - $44.3 $610,493 - $668,930	15,100 Added 66.23%	37,900 $1.64 Million
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $187,818 - $208,978	4,600 Added 25.27%	22,800 $1.01 Million
Q4 2018 Feb 14, 2019	SELL	$41.48 - $45.59 $3.09 Million - $3.4 Million	-74,600 Reduced 80.39%	18,200 $790,000
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $1.12 Million - $1.25 Million	27,900 Added 42.99%	92,800 $4.15 Million
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $1.16 Million - $1.27 Million	-30,800 Reduced 32.18%	64,900 $2.6 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $45.76 $3.18 Million - $3.73 Million	81,500 Added 573.94%	95,700 $3.84 Million
Q4 2017 Feb 14, 2018	SELL	$42.86 - $50.61 $3.23 Million - $3.81 Million	-75,300 Reduced 84.13%	14,200 $611,000
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $3.34 Million - $3.58 Million	71,100 Added 386.41%	89,500 $4.46 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,400	18,400 $885,000

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

Dodge & Cox San Francisco, CA

76.3M
Shares

$3.72 Billion
2.67% of portfolio
Morgan Stanley New York, NY

17.8M
Shares

$866 Million
0.08% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.4M
Shares

$651 Million
0.32% of portfolio
Invesco Ltd. Atlanta, GA

11.7M
Shares

$568 Million
0.13% of portfolio
Bank Of America Corp Charlotte, NC

11.6M
Shares

$564 Million
0.06% of portfolio

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account